WHO To Soon Announce Its Review On India's Covaxin
The World Health Organisation is expected to review and take a final call on an emergency use listing for Covaxin shots on October 26. The organisation is reviewing the data to decide whether the approval will be given for which several Indians are waiting to travel abroad. If all goes well, the positive decision of the WHO will help Indians who've received the vaccine.
Tags: covid 19, Covaxin, Bharat biotech, WHO
Courtesy: Reuters
WHO Team Likely To Approve Covaxin's Emergency Use In Next Meet
Chief Scientist at the World Health Organisation Soumya Swaminathan on October 17 said that the technical advisory group of the WHO will consider the Emergency use listing for Covaxin during the meeting on October 26. If the approval is granted, it'll expand the list of vaccines approved by the WHO to send it to poor countries. Reportedly, Covaxin's manufacturer Bharat Biotech is also hopeful to get the approval.
Tags: Covaxin, WHO, Emergency Use Listing, Bharat biotech
Courtesy: WION
Bharat Biotech Awaits Approval To Roll Out Covaxin To Children Aged 2-8 Yrs
Bharat Biotech after submitting vaccine trial reports of "Covaxin" amongst beneficiaries aged between 2-8 years, said that they are awaiting the approval from the drug regulators. Upon receiving approval, Covaxin will become "one of the first vaccines in the world" to be administered to beneficiaries belonging to the said age group. After reviewing the results, the Subject Expert Committee (SEC) recommended the grant of the vaccine.
Tags: Bharat biotech, Covaxin, DCGI, Vaccine Trial
Courtesy: ANI News
Expert Panel Suggests Covaxin For Children Between 2 To 18 Years
Covaxin, Bharat Biotech's COVID-19 vaccine, was recommended by an expert panel on October 12 for use on children aged two to 18. The company has also received a positive response from the Central Drugs Standard Control Organisation (CDSCO) on its clinical trials. Reportedly, children received the same vaccination as adults in separate trials. However, the company is waiting to get the regulatory approvals to launch it in the market.
Tags: Covid-19, Covid Vaccine, Covaxin, children
Courtesy: NDTV
WHO Expert Panel To Meet, Evaluate Covaxin EUL
The World Health Organization (WHO) has not yet granted Covaxin emergency use Authorization. It is India's domestically produced coronavirus vaccine. On October 5, the Strategic Advisory Group of Experts on Immunization (SAGE) will have a meeting to discuss the Emergency Use Listing (EUL) for Covaxin. The four-day meeting of the expert group to deliberate on policy recommendations began on October 4. Only six vaccine candidates have been… read-more
Tags: WHO, Covid-19, Covid Vaccine, Covaxin
Courtesy: Hindustan Times
Bharat Biotech's Covaxin Is Yet To Receive EUL From WHO
Bharat Biotech had submitted an EOI (Expression of Interest) seeking emergency use listing (EUL) of Covaxin in April 2021. The World Health Organisation is still in the process of the vaccine assessment and is expected to roll out final results by October. Recently in conversation with the media, the company representative told that the company is closely working with WHO to obtain EUL at the earliest.
Tags: Covid-19, WHO, Bharat Bio Tech, Covaxin, Coronavirus Vaccines
Courtesy: The Hindu
Serum Institute Gets Nod To Enroll 7-11 Years Old For Vaccine Trial
As per reports, India's drug regulator has allowed Covishield's maker Serum Institute of India (SII) to enroll children aged between seven to 11 years for its COVID-19 vaccine trial. The Central Drugs Standard Control Organisation's (CDSCO) subject expert panel made the recommendation after "detailed deliberation". SII is already conducting a trial of its COVID-19 vaccine in the 12-17 age group and has presented safety data for an initial 100… read-more
Tags: Serum Institute of India, Covid Vaccination, Covishield vaccine, Covaxin
Courtesy: Reuters
WHO Postpones Covaxin Approval To Oct 5: Covid-19
The approval for Emergency Use Authorisation (EUA) of Covaxin, manufactured by Hyderabad-based Bharat Biotech, is now postponed to October 5, by World Health Organization (WHO). WHO's Strategic Advisory Group on Immunization is scheduled to meet on October 5 to grant Covaxin the EUA. A vaccination safety monitoring strategy will be updated on a global, regional, and national level. EUA will be proposed based on Covaxin's trials.
Tags: Covaxin, Covid-19, Covid Vaccine, WHO, Bharat biotech
Courtesy: NDTV
Bharat Biotech To Produce Additional 200 M Covaxin In Gujarat
India will now receive vaccines in the market as Health Minister Mansukh Mandaviya has released the first commercial batch of COVID-19 vaccine "Covaxin" developed by Bharat Biotech in its new plant, based in Gujarat's Ankleshwar on August 29. Reportedly, the Hyderabad-based firm in may announced to open the plant to produce 200 million doses of vaccine. Mandaviya also said that it will strengthen the country's fight against coronavirus.
Tags: Covaxin, Bharat biotech, Covid Vaccine, Health Minister, Gujarat
Courtesy: Zee News
Covid-19: WHO To Likely Approve Covaxin For Emergency Use
India's indigenous vaccination "Covaxin" developed by Bharat Biotech is all set to receive WHO's approval by the August end for Emergency Use of Listing (EUL). This will help solve the crisis of many Indians who wish to travel to foreign nations. Meanwhile, Health Minister Mr.Mansukh Mandaviya and WHO officials will meet and discuss the Covaxin approval. However, the government claims that it followed the "due diligence for authorization".… read-more
Tags: Covaxin, Bharat biotech, WHO, WHO Approval
Courtesy: The Money Control